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Abstract
With the advancement of microarray technology, it is now possible to study the expression profiles of thousands of genes
across different experimental conditions or tissue samples simultaneously. Microarray cancer datasets, organized as samples
versus genes fashion, are being used for classification of tissue samples into benign and malignant or their subtypes. They
are also useful for identifying potential gene markers for each cancer subtype, which helps in successful diagnosis of
particular cancer types. In this article, we have presented an unsupervised cancer classification technique based on
multiobjective genetic clustering of the tissue samples. In this regard, a real-coded encoding of the cluster centers is used
and cluster compactness and separation are simultaneously optimized. The resultant set of near-Pareto-optimal solutions
contains a number of non-dominated solutions. A novel approach to combine the clustering information possessed by the
non-dominated solutions through Support Vector Machine (SVM) classifier has been proposed. Final clustering is obtained
by consensus among the clusterings yielded by different kernel functions. The performance of the proposed multiobjective
clustering method has been compared with that of several other microarray clustering algorithms for three publicly
available benchmark cancer datasets. Moreover, statistical significance tests have been conducted to establish the statistical
superiority of the proposed clustering method. Furthermore, relevant gene markers have been identified using the
clustering result produced by the proposed clustering method and demonstrated visually. Biological relationships among
the gene markers are also studied based on gene ontology. The results obtained are found to be promising and can
possibly have important impact in the area of unsupervised cancer classification as well as gene marker identification for
multiple cancer subtypes.
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Introduction
The advent of microarray technology has made it possible the
study of the expression profiles of a huge number of genes across
different experimental conditions or tissue samples simultaneously.
This has significant impact on cancer research. Microarray
technology is being utilized in cancer diagnosis through the
classification of the tissue samples. When microarray datasets are
organized as samples versus gene fashion, then they are very
helpful for classification of different types of tissues and
identification of those genes whose expression levels are good
diagnostic indicators. The microarray datasets, where the tissue
samples represent the samples from cancerous (malignant) and
non-cancerous (benign) cells, the classification of them will result in
binary cancer classification. On the other hand, if the samples are
from different subtypes of cancer, then it becomes the problem of
multi-class cancer classification. Multi-class cancer classification
and detection of gene markers for each cancer subtype is a more
challenging task compared to the binary classification.
Most of the researches in the area of cancer diagnosis have
focused on supervised classification of cancer datasets through
training, validation and testing to classify the tumor samples as
malignant or benign, or their subtypes [1–6]. However, unsuper-
vised classification or clustering of tissue samples should also be
studied since in many cases, labeled tissue samples are not
available. In this article, we have explored the application of the
multiobjective genetic clustering for unsupervised classification of
the tissue samples in multi-class cancer data.
A microarray gene expression dataset consisting of g genes and
s tissue samples is typically organized in a 2D matrix E~½eij  of
size s|g. Each element eij represents the expression level of the
jth gene for the ith tissue sample. Clustering [7,8], an important
microarray analysis tool, is used for unsupervised classification of
the tissue samples. Clustering methods partition a set of n objects
into K groups based on some similarity/dissimilarity metric where
the value of K may or may not be known a priori.
Genetic algorithms (GAs) [9] have been effectively used to
develop efficient clustering techniques [10,11]. These techniques
use a single cluster validity measure as the fitness function to reflect
the goodness of an encoded clustering. However, a single cluster
validity measure is seldom equally applicable for different data
properties. This article poses the problem of clustering as a
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objective optimization, in MOO, search is performed over a
number of, often conflicting, objective functions. The final solution
set contains a number of Pareto-optimal solutions, none of which
can be further improved on any one objective without degrading it
in another. Non-dominated Sorting Genetic Algorithm-II (NSGA-
II) [15], a popular evolutionary multiobjective optimization tool,
has been successfully applied in the domain of clustering and
classification in microarray gene expression data [16–18]. In this
article also, an NSGA-II-based multiobjective clustering algorithm
[13] has been adopted that optimizes the cluster compactness and
cluster separation simultaneously. A challenging issue in MOO is
obtaininga final solutionfrom thesetofPareto-optimal solutions.In
this regard, a novel method using Support Vector Machine (SVM)
[19] classifier is described in this article. The procedure utilizes the
points for which most of the non-dominated solutions produce same
class labels to train the SVM classifier with a particular kernel.
Remaining points are classified by the trained classifier. Final
classification is obtained by consensus among the clustering
solutions yielded by different kernel functions.
Furthermore, the clustering solution produced by the proposed
MOGASVM clustering technique has been used to identify the gene
markers that are mostly responsible for distinguishing a particular
tumor class from the remaining ones. Signal-to-Noise ratio (SNR)
statistic-based gene ranking has been utilized for this purpose.
The performance of the proposed MOGASVM clustering
technique has been demonstrated on three publicly available
benchmark cancer datasets, viz., SRBCT, Adult malignancy and
Brain tumor. The superiority of the proposed technique, as
compared to K-means clustering [7], Expectation Maximization
(EM) clustering [20], single objective GA-based clustering that
optimizes the combination of cluster compactness and separation
(SGA), hierarchical average linkage clustering [7], Self Organizing
Map (SOM) clustering [21], consensus clustering [22] and a
recently proposed clustering technique called SiMM-TS [12], is
demonstrated both quantitatively and visually. The superiority of
the MOGASVM clustering technique has also been proved to be
statistically significant through statistical significance tests. Finally,
it has been demonstrated how the MOGASVM clustering result
can be used for identifying the relevant gene markers for the
SRBCT datasets. Also a study of biological relevance of the gene
markers have been conducted based on gene ontology.
Materials and Methods
Multiobjective Optimization using Genetic Algorithms
In many real world situations there may be several objectives
that must be optimized simultaneously in order to solve a certain
problem. This is in contrast to the problems tackled by
conventional GAs, which involve optimization of just a single
criterion. The main difficulty in considering multiobjective
optimization is that there is no accepted definition of optimum
in this case, and therefore it is difficult to compare one solution
with another. In general, these problems admit multiple solutions,
each of which is considered acceptable and equivalent when the
relative importance of the objectives is unknown. The best solution
is subjective and depends on the need of the designer or decision
maker.
Traditional search and optimization methods such as gradient
descent search, and other unconventional ones such as simulated
annealing are difficult to extend as it is to the multiobjective case,
since their basic design precludes the consideration of multiple
solutions. On the contrary, population based methods like
evolutionary algorithms are well suited for handling such
situations. The multiobjective optimization can be formally stated
as [23,24]. Find the vector   x x ~½x 
1,x 
2,...,x 
n 
T of decision
variables which satisfies m inequality constraints:
gi(x)§0, i~1,2,...,m, ð1Þ
p equality constraints
hi(x)~0, i~1,2,...,p, ð2Þ
and optimizes the vector function
f(x)~½f1(x),f2(x),...,fk(x) 
T: ð3Þ
The constraints given in Eqns. (1) and (2) define the feasible region
F which contains all the admissible solutions. Any solution outside
this region is inadmissible since it violates one or more constraints.
The vector   x x  denotes an optimal solution in F. In the context of
multiobjective optimization, the difficulty lies in the definition of
optimality, since it is only rarely that we will find a situation where
a single vector   x x  represents the optimum solution to all the
objective functions.
The concept of Pareto-optimality is useful in the domain of
multiobjective optimization. A formal definition of Pareto-
optimality from the viewpoint of minimization problem may be
given as follows. A decision vector   x x  is called Pareto-optimal if
and only if there is no x that dominates   x x , i.e., there is no x such
that
Vi[1,2,...,k, fi(x)ƒfi(  x x ) and
Ai[1,2,...,k, fi(x)vfi(  x x ):
In other words,   x x  is Pareto-optimal if there exists no feasible
vector x which causes a reduction on some criterion without a
simultaneous increase in at least another. In this context, two other
notions viz., weakly non-dominated and strongly non-dominated solutions
are defined [23]. A point   x x  is a weakly non-dominated solution if
there exists no x such that fi(x)vfi(x ), for i~1,2,...,k. A point
  x x  is a strongly non-dominated solution if there exists no x such
that fi(x)ƒfi(  x x ), for i~1,2,...,k, and for at least one i,
fi(x)vfi(  x x ). In general, Pareto optimum admits a set of solutions
called non-dominated solutions.
There are different approaches for solving multiobjective
optimization problems [23,24], e.g., aggregating, population based
non-Pareto and Pareto-based techniques. In aggregating tech-
niques, the different objectives are generally combined into one
using weighting or goal based method. Vector Evaluated Genetic
Algorithm (VEGA) is a technique in the population based non-
Pareto approach in which different subpopulations are used for the
different objectives. Multiple Objective GA (MOGA), Non-
dominated Sorting GA (NSGA), Niched Pareto GA (NPGA)
constitute a number of techniques under the Pareto-based
approaches. However, all these techniques, described in [24],
are essentially non-elitist in nature. NSGA-II [15], Strength Pareto
Evolutionary Algorithm (SPEA) [25] and SPEA2 [26] are some
more recent elitist techniques. NSGA-II is an improvement over
its previous version NSGA in terms computation time. Moreover,
NSGA-II introduces a novel elitist model by combining the parent
and child populations and propagating the non-dominated
solutions from the combined population to the next generation
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front. Also it proposes a crowded comparison method for binary
tournament selection that provides better diversity in the Pareto
front. In [15], it has been shown that NSGA-II performs better
compared to several other MOO techniques. Hence the multi-
objective clustering technique considered in this work uses NSGA-
II as the underlying optimization framework. However, any other
evolutionary multiobjective optimization tool could have been
used.
NSGA-II based Multiobjective Clustering
In this section, we have described the use of NSGA-II for
evolving a set of near-Pareto-optimal clustering solutions [13].
Cluster compactness and the cluster separation are considered as
the objective functions that are optimized simultaneously. The
technique is described below in detail.
String Representation and Population Initialization. In
the NSGA-II based clustering, the chromosomes are made up of
real numbers which represent the coordinates of the centers of the
clusters. Suppose the size of the dataset is n|d, i.e., the algorithm
clusters n tissue samples each of which is described by d genes
(features). For K clusters, each chromosome thus has a length of
K|d, where d is the data dimension (the number of genes in this
case). As we have used 200 genes that have larger variances across
the samples, the dimension d is therefore 200 for each dataset. The
centers encoded in a chromosome in the initial population are
randomly selected K distinct points from the dataset.
Computing the Objectives. For computing the objective
functions, first the centers V~fv1,v2,...,vKg encoded in a given
chromosome are extracted. Thereafter, each data point is assigned
to its nearest cluster center and the cluster centers are updated by
taking the mean of the points assigned to it. The points are then
reassigned to their nearest cluster centers. The chromosome is also
updated with the new cluster centers.
The global compactness J of a clustering solution is defined as
follows:
J~
X K
i~1
X
xj[Ci
D2(vi,xj), ð4Þ
where D(vi,xj) denotes the distance between the jth point and ith
cluster center. Ci denotes the ith cluster. Note that low value of J
indicates that the clusters are highly compact. Hence the objective
is to minimize J.
The second objective is cluster separation S. This is defined as
follows:
S~
X K
i~1
X K
j~1,i=j
D2(vi,vj): ð5Þ
To obtain well separated clusters, the objective S is to be
maximized. As here NSGA-II is modeled as a minimization
problem, the second objective is taken as the reciprocal of S.
Genetic Operations. The popularly used genetic operations
are selection, crossover and mutation. The selection operation used here
is the crowded binary tournament selection used in NSGA-II [15].
After selection, the selected chromosomes are put in the mating
pool and conventional single point crossover is performed based
on the crossover probability pc. After that, each chromosome
undergoes mutation depending on the mutation probability pm,
where a random cluster center is chosen from it and then moved
slightly.
The most characteristic part of NSGA-II is its elitism operation,
where the parent and child populations are combined and the
non-dominated solutions from the combined population are
propagated to the next generation. For the details on the different
genetic processes, the readers may refer to [15]. The near-Pareto-
optimal strings of the last generation provide the different solutions
to the clustering problem.
Support Vector Machine Classifier
Support vector machine (SVM) classifiers are inspired by
statistical learning theory and they perform structural risk
minimization on a nested set structure of separating hyperplanes
[19,27]. Viewing the input data as two sets of vectors in a
d-dimensional space, an SVM constructs a separating hyperplane
in that space, which maximizes the margin between the two classes
of points. To compute the margin, two parallel hyperplanes are
constructed on each side of the separating one, which are ‘‘pushed
up against’’ the two classes of points. Intuitively, a good separation
is achieved by the hyperplane that has the largest distance to the
neighboring data points of both classes. Larger margin or distance
between these parallel hyperplanes indicates better generalization
error of the classifier. Fundamentally, the SVM classifier is
designed for two-class problems. It can be extended to handle
multi-class problems by designing a number of one-against-all or
one-against-one two-class SVMs.
Suppose a dataset consists of n feature vectors vxi,yiw,
i~f1,2,...,ng, where yi[fz1,{1g, denotes the class label for
the data point xi. The problem of finding the weight vector w can
be formulated as minimizing the following function:
L(w)~
1
2
DDwDD
2, ð6Þ
subject to
yi½w:w(xi)zb §1,i~1,...,n: ð7Þ
Here, b is the bias and the function w(x) maps the input vector to
the feature vector. The dual formulation is given by maximizing
the following:
Q(a)~
X n
i~1
ai{
1
2
X n
i~1
X n
j~1
yiyjaiajK(xi,xj), ð8Þ
subject to
X n
i~1
yiai~0 and 0ƒaiƒC, i~1,...,n: ð9Þ
Only a small fraction of the ai coefficients are nonzero. The
corresponding pairs of xi entries are known as support vectors and
they fully define the decision function. Geometrically, the support
vectors are the points lying near the separating hyperplane. Here
K(xi,xj)~w(xi):w(xj) is called the kernel function.
Kernel functions help to map the feature space into higher
dimensional space. The kernel function may be linear or non-
linear, like polynomial, sigmoidal, radial basis functions (RBF), etc.
The four kernel functions used in this article are as follows:
Linear: K(xi,xj)~xT
i xj
Polynomial: K(xi,xj)~(cxT
i xjzr)
d
Sigmoidal: K(xi,xj)~tanh(k(xT
i xj)zh)
Radial Basis Function (RBF): K(xi,xj)~e{cDxi{xjD2
.
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multi-class classification problem by designing a number of one-
against-all two-class SVMs [27] is used here. For example, a K-
class problem is handled with K two-class SVMs, each of which is
used to separate a class of points from all the remaining points.
Obtaining the Final Clustering from the Non-dominated
Solutions
As the multiobjective clustering produces a set of non-
dominated solutions in the final generation, it is required to apply
some technique to obtain the final clustering solution from this set.
This section describes the proposed scheme for combining the
NSGA-II-based multiobjective clustering algorithm with the SVM
classifier for this purpose. In the combined approach, named
MOGASVM, each non-dominated solution is given equal
importance and a majority voting technique is applied. This is
motivated by the fact that due to the presence of training points,
supervised classification usually performs better than the unsuper-
vised classification or clustering. Here we have exploited this
advantage while selecting some training points using majority
voting on the non-dominated solutions produced by the multi-
objective clustering. The majority voting technique gives a set of
points for which most of the non-dominated solutions assign the
same class labels. Hence these points can be thought to be
clustered properly and thus can be used as the training points of
the SVM classifier. Subsequently, the remaining low-confidence
points are classified using the trained classifier. The process is
repeated for different kernel functions and the final clustering is
obtained through majority voting among the cluster label vectors
produced by the different kernel functions. The steps of
MOGASVM are described below.
Step 1: Execute MOGA clustering to obtain a set
S~fs1,s2,...,sNg, NƒP, of non-dominated solution strings
consisting of cluster centers.
Step 2: Decode each solution si[S and obtain the cluster label
vector for each solution by assigning each point to its nearest
cluster center.
Step 3: Reorganize the cluster label vectors to make them
consistent, i.e., cluster k in the first solution should correspond to
cluster k in all other solutions. For example, the cluster label vector
f1122233g is equivalent to f2233311g.
Step 4: Mark the points which are given the same class label k
for at least bN solutions, as the training points, where b, 0vbƒ1,
is the majority voting threshold. The class labels of the points will
be class k.
Step 5: Train the SVM classifier with some kernel function
using the training points.
Step 6: Generate the class labels for the remaining points using
the trained SVM classifier.
Step 7: Repeat Steps 5–6 for the four kernel functions
considered here and obtain the four cluster label vectors.
Step 8: Combine the four clustering label vectors through
majority voting ensemble, i.e., each point is assigned a class label
that obtains the maximum number of votes among the four
clustering solutions. Ties are broken randomly.
The sizes of the training and testing sets depend on the
parameter b (majority voting threshold), which determines the
minimum number of non-dominated solutions that must agree
with each other in the voting context. If b has a high value, the size
of the training set is small. However it implies that more number of
non-dominated solutions agree with each other and thus
confidence of the training set is high. On the contrary, if b has
a low value, the size of the training set is large. But it indicates that
less number of non-dominated solutions have agreement among
themselves and the training set has low confidence level. During
experimentation, we have tried different values for b and found
that the performance of MOGASVM is in general best when b is
in the range between 0.4 and 0.6. This has been observed for all
the datasets considered here. Therefore, to achieve a tradeoff
between the size and confidence of the training set, after several
experiments, we have set the parameter b to a value of 0.5.
However, this parameter can be exposed to the user who can tune
it according to his/her need.
Number of Clusters
For setting the number of clusters K, silhouette index is used
[28]. It is defined as follows. Suppose a represents the average
distance of a point from the other points of the cluster to which the
point is assigned, and b represents the minimum of the average
distances of the point from the points of the other clusters. Now
the silhouette width s of the point is defined as:
s~
b{a
maxfa,bg
: ð10Þ
Silhouette index S is the average silhouette width of all the data
points (tumor samples) and it reflects the compactness and
separation of the clusters. The value of silhouette index varies
from 21 to 1 and higher value indicates better clustering result.
The value of S does not have any monotonic increasing or
decreasing tendency with the number of clusters. Hence this index
is a good indicator for selecting the number of clusters [28].
To select the number of clusters K, the MOGASVM algorithm
is run for different values of K starting from 2 to
ﬃﬃﬃ
n
p
, n being the
number of data points. For each K, it is executed 10 times from
different initial configurations and the run giving the best S value
is taken. Among these best solutions for different K values, the
value of K for the solution producing the maximum S index value
is chosen. The same K value is used for all the algorithms for a fair
comparison.
Dealing with the Outliers
It is known that the presence of outliers can affect the performance
of the clustering algorithms. The proposed MOGASVM clustering
algorithm computes the means of the clusters during chromosome
updation which is likely to be affected due to the presence of outliers
in the dataset. To cope with this, we modified the proposed algorithm
as follows. During the chromosome updation, instead of taking the
means of the points in a cluster, we compute the medoid of the cluster.
A cluster medoid, unlike cluster mean, is an actual data point in the
cluster from which the sum of the distances to the other points of the
cluster is minimum. Since medoid is an actual data point, it is less
influenced by the presence of outliers [29]. The rest of the steps of the
modified algorithm remains same. During experimentation, it has
been found that the medoid-based multiobjective clustering algo-
rithm performs similarly as the mean-based approach for the three
datasets considered in this article. Thereforewe have not reported the
results for the medoid-based approach. This suggests that the datasets
consideredherearepossiblyfreefromoutliers.However,thismaynot
be true for the other datasets and in that case, it will be better to use
the medoid-based approach instead of the mean-based one. It is to be
noted that finding the medoids is computationally more expensive
t h a nf i n d i n gt h em e a n s .B u ti ti sp o s s i b l et op r e c o m p u t et h ec o m p l e t e
distance matrix and keep it in memory during the execution of the
clustering algorithm for faster performance, because the number of
samples in sample-gene microarray datasets is usually much smaller
compared to the number of genes.
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Two performance measures, i.e., percentage Classification
Accuracy (%CA) and Adjusted Rand Index (ARI) are considered
for comparing the results produced by different algorithms. These
are defined below.
Percentage Classification Accuracy. We define the
percentage Classification Accuracy (%CA) to compare a
clustering solution with the true clustering. Suppose T is the
true clustering of the samples in a gene expression dataset and C is
a clustering result given by some clustering algorithm. Let a be the
number of pairs of points that belong to the same clusters in both
T and C, b be the number of pairs of points that belong to
different clusters in both T and C, and c be the total number of
pairs of points, i.e.,
n
2
  
. The %CA is defined as:
%CA(T,C)~
azb
c
|100: ð11Þ
Higher value of %CA means a better matching between T and C.
Evidently %CA(T,T)~100%.
Adjusted Rand Index. The Adjusted Rand index (ARI) [30]
is also used to compare a clustering solution with the true
clustering. Suppose T is the true clustering of the samples in a gene
expression dataset and C is a clustering result given by some
clustering algorithm. Let a, b, c and d respectively denote the
number of pairs of points belonging to the same cluster in both T
and C, the number of pairs belonging to the same cluster in T but
to different clusters in C, the number of pairs belonging to
different clusters in T but to the same cluster in C, and the
number of pairs belonging to different clusters in both T and C.
The adjusted Rand index ARI(T,C) is then defined as follows:
ARI(T,C)~
2(ad{bc)
(azb)(bzd)z(azc)(czd)
: ð12Þ
The value of ARI(T,C) lies between 0 and 1 and higher value
indicates that C is more similar to T. Evidently, ARI(T,T)~1.
Identification of the Gene Markers
In this section we have demonstrated how the proposed
MOGASVM clustering technique can be used to identify the
Table 1. The comparison of the average ARI and %CA scores
produced by 50 consecutive runs of MOGASVM with
ensemble of kernel functions and MOGASVM with individual
kernel functions for all the datasets.
Algorithms SRBCT
Adult
malignancy Brain tumor
ARI %CA ARI %CA ARI %CA
MOGASVM 0.5126 76.6412 0.8172 96.4718 0.7172 88.5150
MOGASVM
(linear)
0.4726 74.7926 0.7591 95.8244 0.6836 87.5836
MOGASVM
(polynomial)
0.4682 74.5343 0.7238 94.7375 0.6927 88.0116
MOGASVM
(sigmoidal)
0.4816 76.0284 0.7704 95.7581 0.6734 87.2046
MOGASVM
(RBF)
0.4855 76.2891 0.7926 96.2183 0.7025 88.1173
doi:10.1371/journal.pone.0013803.t001
Table 2. The average ARI and %CA scores produced by 50
consecutive runs of different algorithms for the SRBCT data.
Algorithms ARI %CA
MOGASVM 0.5126 76.6412
K-means 0.3135 70.1903
EM 0.3376 71.1295
SGA 0.3198 70.8193
Avg. linkage 0.1021 49.0527
SOM 0.3872 71.7845
SiMM-TS 0.4628 74.4853
CSPA 0.3922 72.0297
HGPA 0.2839 67.4533
MCLA 0.3902 71.9764
doi:10.1371/journal.pone.0013803.t002
Table 3. The average ARI and %CA scores produced by 50
consecutive runs of different algorithms for the Adult
malignancy data.
Algorithms ARI %CA
MOGASVM 0.8172 96.4718
K-means 0.6924 92.5441
EM 0.7251 94.7294
SGA 0.7491 95.7858
Avg. linkage 0.6190 93.0437
SOM 0.5917 92.8100
SiMM-TS 0.7823 96.0139
CSPA 0.7331 95.0801
HGPA 0.7192 94.0549
MCLA 0.7398 95.2813
doi:10.1371/journal.pone.0013803.t003
Table 4. The average ARI and %CA scores produced by 50
consecutive runs of different algorithms for the Brain tumor
data.
Algorithms ARI %CA
MOGASVM 0.7172 88.5150
K-means 0.5764 84.5144
EM 0.5581 83.1457
SGA 0.6325 87.1433
Avg. linkage 0.4603 78.2811
SOM 0.6214 87.0376
SiMM-TS 0.6892 87.9110
CSPA 0.6028 85.9984
HGPA 0.5295 83.9416
MCLA 0.5974 86.4543
doi:10.1371/journal.pone.0013803.t004
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different classes of tissue samples. Here we have demonstrated the
process for the SRBCT dataset (described in the next section). This
has been done as follows.
At first, MOGASVM is applied to cluster the samples of the
preprocessed dataset into four classes corresponding to the tumor
subtypes EWS, NB, BL and RMS, respectively. To obtain the
gene markers for the EWS subtype, the clustering result is treated
as two classes: one class corresponds to the EWS tumors and the
other class corresponds to the remaining tumor types. Considering
these two classes, for each of the genes, a statistic called Signal-to-
Noise Ratio (SNR) [1] is computed. The SNR is defined as
SNR~
m1{m2
s1zs2
, ð13Þ
where mi and si, i[f1,2g, respectively denote the mean and
standard deviation of class i for the corresponding gene. Note that
larger absolute value of SNR for a gene indicates that the gene’s
expression level is high in one class and low in another. Hence this
bias is very useful in distinguishing the genes that are expressed
differently in the two classes of samples. After computing the SNR
statistic for each gene, the genes are sorted in descending order of
their SNR values. From the sorted list, top 10 genes are selected as
the gene markers (5 down-regulated, i.e., negative SNR and 5 up-
regulated, i.e., positive SNR) for the EWS subtype. The top 10
gene markers for the other tumor subtypes are selected similarly,
i.e., by considering two classes each time, one corresponding to the
tumor class for which the gene markers are being identified, and
the other corresponding to all the remaining tumor classes.
It has been observed that the set of top 10 genes selected in
different runs of MOGASVM varies slightly from one run to
another. So while reporting the final gene markers for the SRBCT
data, we have reported the most frequently selected 10 genes over
all the runs. The frequencies of the selected genes have also been
reported. Moreover, the clustering result obtained using the 40
marker genes for the SRBCT data (10 for each of the 4 cancer
subtypes) is compared with the clustering results obtained using
initially selected 200 genes to show the effectiveness of using only
the marker genes for clustering.
Datasets
In this article, three publicly available benchmark cancer
datasets, viz., SRBCT, Adult malignancy and Brain tumor datasets have
been used for experiments. The datasets are described in this
section.
                 
Figure 1. The boxplots showing the %CA index scores produced by different algorithm over 50 consecutive runs for the SRBCT
dataset.
doi:10.1371/journal.pone.0013803.g001
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round blood cell tumors (SRBCT) are 4 different childhood
tumors named so because of their similar appearance on routine
histology [5]. The number of samples is 63 and total number of
genes is 2308. They include Ewing’s family of tumors (EWS) (23
samples), neuroblastoma (NB) (8 samples), Burkitt’s lymphoma
(BL) (12 samples) and rhabdomyosarcoma (RMS) (20 samples).
This dataset is publicly available at http://www.ailab.si/supp/
bi-cancer/projections/info/SRBCT.htm.
Adult Malignancy. This data consists of 190 tumor samples,
spanning 14 common tumor types to oligonucleotide microarray
[6]. The 14 tumor types are: breast adenocarcinoma (BR) (11
samples), prostate adenocarcinoma (PR) (10 samples), lung
adenocarcinoma (LU) (11 samples), colorectal adenocarcinoma
(CR)(11samples),lymphoma(LY)(22samples),bladdertransitional
cell carcinoma (BL) (10 samples), melanoma (ML) (11 samples),
uterine adenocarcinoma (UT) (10 samples), leukemia (LE) (30
samples), renal cell carcinoma (RE) (11 samples), pancreatic
adenocarcinoma (PA) (11 samples), ovarian adenocarcinoma (OV)
(11 samples), pleural mesothelioma (ME) (11 samples) and central
nervous system (CNS) (20 samples). The number of genes is 1363.
This dataset is publicly available at the following website: http://
algorithmics.molgen.mpg.de/Static/Supplements/CompCancer.
Brain Tumor. Embryonal tumors of the central nervous
system (CNS) represent a heterogeneous group of tumors [6]. The
dataset contains five types of tumor samples viz., primitive
neuroectodermal tumors (PNETs) (8 samples), atypical teratoid/
rhabdoidtumors(Rhab)(10samples),malignantgliomas(Mglio)(10
samples), medulloblastomas (MD) (10 samples) and normal tissues
(Ncer) (4 samples). The number of genes in this dataset is 1379. This
dataset is also publicly available at the following website: http://
algorithmics.molgen.mpg.de/Static/Supplements/CompCancer.
Preprocessing of the Datasets
Each dataset is subjected to the following preprocessing steps to
find out the genes with most variability across the samples. At first,
for each gene, we have calculated its variance across all the
samples. Thereafter, the genes are sorted in descending order of
their variances. Subsequently, from all the genes, the top 200
genes with the largest variance across the samples are selected.
This is done with the expectation that the genes having larger
variance across the samples are more effective in distinguishing
different classes of tumor samples rather than the genes with small
variance across the samples. Next, the expression values are log-
transformed. Finally, each sample is normalized to have mean 0
and variance 1.
Results and Discussion
The performance of the proposed MOGASVM clustering has
been compared with that of K-means clustering [20], Expectation
Maximization (EM) clustering [20], single objective GA minimiz-
ing
J
S
(SGA), hierarchical average linkage clustering [7], Self
Organizing Map (SOM) clustering [21], SiMM-TS clustering [12]
and consensus clustering [22]. Under consensus clustering, three
cluster ensemble approaches as found in [22], namely, Cluster-
based Similarity Partitioning Algorithm (CSPA), HyperGraph
Partitioning Algorithm (HGPA) and Meta-CLustering Algorithm
(MCLA) are studied. The clustering solutions found by the K-
means, EM, average linkage and SOM clustering have been
combined through these three cluster ensemble techniques. We
have tested two well-known distance measures viz., Euclidean and
Pearson Correlation based distance. However as the datasets are
normalized so that each row has mean 0 and variance 1, it is
known that both Euclidean and correlation based distance
perform similarly. Therefore, in this section, we have reported
the results for Euclidean distance only.
Input Parameters
The different parameters of MOGA and SGA are taken as
follows: number of generations=100, population size=50,
                 
Figure 2. The boxplots showing the %CA index scores produced by different algorithm over 50 consecutive runs for the Adult
malignancy dataset.
doi:10.1371/journal.pone.0013803.g002
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value of the parameters b is taken as 0.5. The parameters have been
set after several experiments. It has been found during experimen-
tation that the best clustering is actually obtained with lower
number of generations and smaller population size for all the
datasets. However, to make it standard and consistent for all the
datasets considered here, we have chosen the aforementioned
parameter setting to obtain good clustering result within reasonable
time. The probabilities of crossover and mutation are also selected
experimentally and found to be reasonably robust around the
selected values. The K-means, EM and SOM clustering have been
run for 5000 iterations unless they converge before that. In each run
of hierarchical average linkage clustering, K-means, EM and SOM,
the clustering solutions are combined using CSPA, HGPA and
MCLA ensemble approaches to obtain the consensus clustering.
Clustering Performance
Firstly, in Table 1, we have reported the average ARI index and
%CA index scores over 50 consecutive runs of MOGASVM (with
majority voting ensemble of four kernel functions) and MO-
                 
Figure 3. The boxplots showing the %CA index scores produced by different algorithm over 50 consecutive runs for the Brain
tumor dataset.
doi:10.1371/journal.pone.0013803.g003
Table 5. The P-values produced by t-test comparing MOGASVM with the other algorithms.
P-values
datasets (comparing mean values of %CA index of MOGASVM with other algorithms)
K-means EM SGA Avg. Link SOM SiMM-TS CSPA HGPA MCLA
SRBCT 3.1E-07 2.17E-07 2.41E-03 1.08E-06 6.5E-05 5.32E-03 3.23E-04 6.38E-06 2.94E-04
Adult malignancy 2.21E-05 1.67E-08 3.4E-05 4.52E-12 1.44E-04 2.53E-03 7.2E-04 2.3E-06 1.4E-04
Brain tumor 3.42E-05 7.43E-08 5.8E-05 2.7E-07 2.1E-05 1.4E-04 8.92E-05 6.2E-06 9.3E-05
doi:10.1371/journal.pone.0013803.t005
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considered in this article. It is evident from the performance index
scores that the ensemble of kernel functions performs better than
the individual kernel functions. This demonstrates the utility of
MOGASVM with ensemble of kernel functions rather than using
the four kernel functions individually.
Figure 4. The heatmap of the expression levels of the most frequently selected top 10 gene markers for each tumor subtype in the
SRBCT data. Red/green represents up/down regulation relative to black. Each subgroup is in a yellow box to identify its samples and the
distinguishing gene markers. The image clone IDs of the marker genes are also shown on the right side of the genes.
doi:10.1371/journal.pone.0013803.g004
Table 6. The gene markers in the SRBCT data for the EWS class, their Image IDs, symbols, selection frequencies, descriptions and
up/down regulation natures.
Gene Image ID Symbol Frequency % Description Up/Down
782811 HMGA1 100 high-mobility group (nonhistone chromosomal) Down
protein isoforms I and Y
796646 ODC1 100 ornithine decarboxylase 1 Down
810899 CKS1B 96 CDC28 protein kinase regulatory subunit 1B Down
745138 TUBA3D 96 tubulin, alpha Down
30093 RANBP1 90 RAN binding protein Down
866702 PTPN13 100 protein tyrosine phosphatase, non-receptor type 13 Up
(APO-1/CD95 (Fas)-associated phosphatase)
811028 TMEM49 98 transmembrane protein 49 Up
505491 PTTG1IP 98 pituitary tumor-transforming 1 interacting protein Up
470261 SMA4 94 glucuronidase, beta pseudogene Up
814260 KDSR 92 3-ketodihydrosphingosine reductase Up
doi:10.1371/journal.pone.0013803.t006
Clustering Cancer Subtypes
PLoS ONE | www.plosone.org 9 November 2010 | Volume 5 | Issue 11 | e13803Tables 2,3,4 report the average ARI index and average %CA
index scores over the 50 runs of each algorithm considered in this
article, respectively, for the SRBCT, Adult malignancy and Brain
tumor datasets. For all the three datasets, the silhouette index has
found the correct number of clusters. As is evident from the tables,
MOGASVM produces the best average ARI index and %CA
index scores compared to the other algorithms.
From the tables, it appears that MOGASVM also outperforms
its single objective counterpart SGA that optimizes the combina-
tion of cluster compactness and cluster separation. On the other
hand, MOGASVM optimizes both of these objectives simulta-
neously. As MOGASVM performs better in terms of both the
performance scores, it indicates that optimizing multiple criteria
simultaneously can yield better clustering rather than the case
when the objectives are combined into one.
For the purpose of illustration, Figures 1,2,3 show the boxplots
representing the %CA scores over 50 runs of the algorithms for the
three datasets considered here. It is evident from the figures that
the boxplots corresponding to MOGASVM are situated at the
upper side of the figures, which indicates that MOGASVM
produces higher %CA scores than those produced by the other
algorithms. SiMM-TS has been found to be the closest competitor
of MOGASVM for all the datasets.
Execution Time
All the algorithms have been implemented in Matlab and
executed on an Intel Core 2 Duo 2.0 GHz Machine with 2 GB
memory having Windows XP operating system. It should be noted
that time requirement for the GA based clustering techniques is
usually more because of the different genetic operations performed
during the execution of the algorithms. On average, MOGASVM
executes for 97.24 seconds for the SRBCT dataset, whereas the
SGA and SiMM-TS clustering takes 75.93 and 161.37 seconds,
respectively. The other algorithms execute only for a few seconds
for this dataset. The execution times have been computed on the
basis of the parameter settings discussed in the Input Parameters
section. As expected, the execution time of MOGASVM is larger
compared to the other single objective clustering methods because
of some additional operations necessitated by its multiobjective
nature. Only SiMM-TS takes more time than it, because SiMM-
Table 7. The gene markers in the SRBCT data for the NB class, their Image IDs, symbols, selection frequencies, descriptions and
up/down regulation natures.
Gene Image ID Symbol Frequency % Description Up/Down
207274 IGF2 100 Human DNA for insulin-like growth factor II (IGF-2); Down
exon 7 and additional ORF
563673 ALDH7A1 100 aldehyde dehydrogenase 7 family, member A1 Down
1416782 CKB 100 creatine kinase, brain Down
296448 IGF2 96 insulin-like growth factor 2 (somatomedin A) Down
250654 SPARC 92 secreted protein, acidic, cysteine-rich (osteonectin) Down
812965 MYC 100 v-myc avian myelocytomatosis viral oncogene homolog Up
344134 IGLL1 100 immunoglobulin lambda-like polypeptide Up
840942 HLA-DPB1 94 major histocompatibility complex, class II, DP beta Up
868304 ACTA2 94 actin, alpha 2, smooth muscle, aorta Up
745343 REG1A 90 regenerating islet-derived 1 alpha Up
(pancreatic stone protein, pancreatic thread protein)
doi:10.1371/journal.pone.0013803.t007
Table 8. The gene markers in the SRBCT data for the BL class, their Image IDs, symbols, selection frequencies, descriptions and
up/down regulation natures.
Gene Image ID Symbol Frequency % Description Up/Down
784224 FGFR4 100 fibroblast growth factor receptor Down
365826 GAS1 98 growth arrest-specific Down
810057 CSDA 98 cold shock domain protein A Down
839552 NCOA1 94 nuclear receptor coactivator Down
244618 FNDC5 94 fibronectin type III domain containing 5 Down
878652 PCOLCE 100 procollagen C-endopeptidase enhancer Up
327350 HNRNPA2B1 100 heterogeneous nuclear ribonucleoprotein A2/B1 Up
824041 SFRS9 100 splicing factor, arginine/serine-rich Up
950574 H3F3B 96 H3 histone, family 3B (H3.3B) Up
812105 MLLT11 92 myeloid/lymphoid or mixed-lineage leukemia Up
(trithorax homolog, Drosophila); translocated to, 11
doi:10.1371/journal.pone.0013803.t008
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always converged far before reaching the maximum number of
iterations. However, as is evident from the results, the clustering
performance of MOGASVM is the best among all the methods for
all the datasets considered in this article. It is also found during
experimentation that even if the other algorithms used for
comparison are allowed to run for the time taken by MOGASVM,
they are not able to improve their clustering results any further.
The average execution times of MOGASVM for the Adult
malignancy and the Brain tumor datasets are 212.76 and
81.28 seconds, respectively. The timing requirements of the
proposed technique can be reduced further by using a stopping
criterion based on some test of convergence of the multiobjective
evolutionary process.
Statistical Significance Test
To establish that MOGASVM is significantly superior to the
other algorithms, a statistical significance test called t-test has been
conducted at 5% significance level. Ten groups, corresponding to
the ten algorithms (1. MOGASVM, 2. K-means, 3. EM, 4. SGA,
5. average linkage, 6. SOM, 7. SiMM-TS, 8. CSPA, 9. HGPA, 10.
MCLA) have been created for each dataset. Each group consists of
the %CA index scores produced by 50 consecutive runs of the
corresponding algorithm.
As is evident from the Tables 2,3,4, the average values of the
%CA scores for MOGASVM are better than those for the other
algorithms. To establish that this goodness is statistically
significant, Table 5 reports the P-values produced by t-test for
comparison of two groups (the group corresponding to MO-
GASVM and a group corresponding to some other algorithm) at a
time. As a null hypothesis, it is assumed that there is no significant
difference in the mean values of the two groups. Whereas, the
alternative hypothesis is that there is significant difference in the
mean values of the two groups. All the P-values reported in the
table are less than 0.05 (5% significance level). This is a strong
evidence against the null hypothesis, indicating that the better
mean values of the %CA index produced by MOGASVM are
statistically significant and have not occurred by chance.
Gene Markers for the SRBCT Dataset
In Figure 4 we have shown the heatmap of the gene versus
sample matrix of the SRBCT dataset, where the rows correspond
to the most frequently selected top 10 genes in terms of SNR
statistic scores for each tumor subtype depicted in the columns.
Table 9. The gene markers in the SRBCT data for the RMS class, their Image IDs, symbols, selection frequencies, descriptions and
up/down regulation natures.
Gene Image ID Symbol Frequency % Description Up/Down
627939 CSRP3 100 cysteine and glycine-rich protein 3 Down
(cardiac LIM protein)
52076 OLFM1 100 olfactomedinrelated ER localized protein Down
781097 RTN3 100 neurotrophic tyrosine kinase, receptor-related Down
841620 DPYSL2 98 dihydropyrimidinase-like Down
377461 CAV1 98 caveolin 1, caveolae protein, 22kD Down
878798 B2M 100 beta-2-microglobulin Up
770394 FCGRT 98 Fc fragment of IgG, receptor, transporter, alpha Up
263716 COL6A1 98 collagen, type VI, alpha Up
461425 MYL4 96 myosin light chain 4 Up
298062 TNNT2 96 troponin T2, cardiac Up
doi:10.1371/journal.pone.0013803.t009
Table 10. The significant GO terms shared by the gene markers in the SRBCT data for the EWS class. Level refers to the GO Level.
Level GO term Module % Genome %
3 cellular component organization and biogenesis (GO:0016043) 50.0 18.3
4 transport (GO:0006810) 42.86 18.33
3 multicellular organismal development (GO:0007275) 25.0 15.83
3 nitrogen compound metabolic process (GO:0006807) 12.5 3.24
3 protein localization (GO:0008104) 12.5 5.28
4 carbohydrate metabolic process (GO:0005975) 14.29 3.72
4 amino acid and derivative metabolic process (GO:0006519) 14.29 2.48
6 DNA replication (GO:0006260) 14.29 1.7
6 biogenic amine metabolic process (GO:0006576) 14.29 0.52
Module % is the percentage of the genes involved in the particular GO term among the gene markers. Genome % is the percentage of genes involved in the particular
GO term among the complete genome.
doi:10.1371/journal.pone.0013803.t010
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markers, 10 for each of the four classes. The cells of the heatmap
represent the expression levels of the genes in terms of colors. The
shades of red represent high expression levels, the shades of green
represent low expression levels and the colors towards black
represent the absence of differential expression values. It is evident
from the figure that the gene markers for each tumor subtypes
have either high expression values (up-regulated) or low expression
values (down-regulated) over all the samples of the respective
tumor class. In Tables 6,7,8,9, we have reported the top 10 gene
markers along with their description and up/down regulation
states for the EWS, NB, BL and RMS tumor classes, respectively.
Also the frequency of selection of each gene over 50 runs of
MOGASVM is reported. For the EWS class, the genes 782811
(HMGA1), 796646 (ODC1), 810899 (CKS1B), 745138 (TU-
BA3D) and 30093 (RANBP1) are down-regulated and the genes
866702 (PTPN13), 811028 (TMEM49), 505491 (PTTG1IP),
470261 (SMA4) and 814260 (KDSR) are up-regulated. It is
interesting to observe that these genes behave almost oppositely in
the remaining tumor classes (Figure 4). For the NB class, the genes
207274 (IGF2), 563673 (ALDH7A1), 1416782 (CKB), 296448
(IGF2) and 250654 (SPARC) are down-regulated and the genes
812965 (MYC), 344134 (IGLL1), 840942 (HLA-DPB1), 868304
(ACTA2) and 745343 (REG1A) are up-regulated. For the BL
class, the down-regulated genes are 784224 (FGFR4), 365826
(GAS1), 810057 (CSDA), 839552 (NCOA1) and 244618
(FNDC5), whereas the up-regulated genes are 878652 (PCOLCE),
327350 (HNRNPA2B1), 824041 (SFRS9), 950574 (H3F3B) and
812105 (MLLT11). Lastly, for the RMS class, the down-regulated
and up-regulated genes are 627939 (CSRP3), 52076 (OLFM1),
781097 (RTN3), 841620 (DPYSL2), 377461 (CAV1) and 878798
(B2M), 770394 (FCGRT), 263716 (COLGA1), 461425 (MYL4),
298062 (TNNT2), respectively.
Among the above gene markers, many of those have already
been validated to be associated with the respective cancer classes
in different existing literature. For example, the gene PTPN13 has
been shown to be over-expressed for EWS (thus has been treated
as a marker for the EWS class) in [31]. In [32] and [33], the
relation of IGF2 with neuroblastoma (NB) has been investigated
and IGF2 has been found to be a good marker for the NB class.
For another gene CKB, it has been stated in [34] that the cytosolic
CKB is induced in a variety of tumors, including neuroblastoma.
Moreover, the work in [35] reveals that the gene SPARC potently
inhibits angiogenesis and significantly impairs the NB tumor
growth in vivo. In [36], the role for b2-Microglobulin (B2M) in
echovirus infection of rhabdomyosarcoma (RMS) cells has been
investigated. The gene MYL4 has been shown to be over-
expressed in Alveolar rhabdomyosarcoma (ARMS) class by gene
expression profiling. Finally, TNNT2 has also been shown to be
highly expressed for the RMS class in [37]. This discussion
indicates that our approach has identified many potential gene
markers that are also shown to be associated with the respective
cancer types in different existing studies. Therefore, it will be
interesting to conduct some biological experimentation to
investigate the roles of the other marker genes selected in this
work.
To look into the biological relationship among the selected gene
markers, gene ontology based study has been conducted using
FatiGO (http://babelomics.bioinfo.cipf.es/). The outcome of the
study has been reported in Tables 10,11,12,13 for the gene
Table 11. The significant GO terms shared by the gene markers in the SRBCT data for the NB class.
Level GO term Module % Genome %
3 cell proliferation (GO:0008283) 42.86 5.46
3 immune response (GO:0006955) 28.57 5.38
3 cell cycle (GO:0007049) 28.57 6.23
3 response to abiotic stimulus (GO:0009628) 14.29 1.02
3 antigen processing and presentation (GO:0019882) 14.29 0.84
3 tissue remodeling (GO:0048771) 14.29 0.75
6 regulation of progression through cell cycle (GO:0000074) 40.0 4.55
7 transmembrane receptor protein tyrosine 66.67 1.9
kinase signaling pathway (GO:0007169)
Level refers to the GO Level. Module % is the percentage of the genes involved in the particular GO term among the gene markers. Genome % is the percentage of
genes involved in the particular GO term among the complete genome.
doi:10.1371/journal.pone.0013803.t011
Table 12. The significant GO terms shared by the gene markers in the SRBCT data for the BL class.
Level GO term Module % Genome %
3 response to stress (GO:0006950) 69.72 7.24
4 mitotic cell cycle (GO:0000278) 16.67 2.04
6 regulation of progression through cell cycle (GO:0000074) 16.67 4.45
8 S phase of mitotic cell cycle (GO:0000084) 20.0 0.14
9 RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) 25.0 1.83
Level refers to the GO Level. Module % is the percentage of the genes involved in the particular GO term among the gene markers. Genome % is the percentage of
genes involved in the particular GO term among the complete genome.
doi:10.1371/journal.pone.0013803.t012
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respectively. Each table reports a list of GO terms (under
biological process category) shared by the marker genes of the
corresponding tumor class. For each GO term, the percentage of
genes sharing that term among the marker genes and percentage
of genes sharing that term among the whole genome have been
reported. It is evident from the tables that the percentage among
the gene markers is much higher than the percentage among the
whole genome. This indicates that the gene markers of a particular
tumor class are more involved in similar biological processes
compared to the remaining genes of the genome.
For the purpose of illustration, the %CA scores have been
computed for the clustering solutions generated by all the
algorithms on the complete preprocessed SRBCT dataset (with
the initially selected 200 genes) and on the reduced dataset
consisting of only the marker genes as selected using the SNR
Table 13. The significant GO terms shared by the gene markers in the SRBCT data for the RMS class.
Level GO term Module % Genome %
3 circulation (GO:0008015) 25.0 1.07
3 antigen processing and presentation (GO:0019882) 25.0 0.84
3 multicellular organismal development (GO:0007275) 50.0 15.83
3 anatomical structure development (GO:0048856) 50.0 14.44
3 cellular developmental process (GO:0048869) 50.0 15.58
3 regulation of biological quality (GO:0065008) 25.0 4.14
3 immune response (GO:0006955) 25.0 5.38
4 endothelial cell proliferation (GO:0001935) 12.5 0.09
4 homeostatic process (GO:0042592) 25.0 2.73
4 cell differentiation (GO:0030154) 50.0 16.04
6 regulation of endothelial cell proliferation (GO:0001936) 20.0 0.09
6 cardiac inotropy (GO:0002026) 20.0 0.05
6 muscle development (GO:0007517) 40.0 1.47
6 sterol transport (GO:0015918) 20.0 0.06
6 glycerolipid metabolic process (GO:0046486) 20.0 0.19
7 negative regulation of endothelial cell proliferation (GO:0001937) 25.0 0.07
7 cholesterol transport (GO:0030301) 25.0 0.08
7 regulation of nitric oxide biosynthetic process (GO:0045428) 25.0 0.09
7 cardiac muscle development (GO:0048738) 25.0 0.05
9 protein oligomerization (GO:0051259) 66.67 1.22
Level refers to the GO Level. Module % is the percentage of the genes involved in the particular GO term among the gene markers. Genome % is the percentage of
genes involved in the particular GO term among the complete genome.
doi:10.1371/journal.pone.0013803.t013
Table 14. The performance of the clustering algorithms on the SRBCT dataset with the initially selected 200 genes, the marker
genes selected using the t-statistic and the marker genes selected using the SNR statistic.
Algorithms %CA
Initially selected Markers selected Markers selected
200 genes by the t-statistic by the SNR statistic
MOGASVM 76.6412 85.8293 90.3781
K-means 70.1903 80.3772 85.3914
EM 71.1295 82.3371 86.8934
SGA 70.8193 81.1823 86.4927
Avg. linkage 49.0527 70.2947 76.9837
SOM 71.7845 82.7845 86.9833
SiMM-TS 74.4853 84.9648 89.1397
CSPA 72.0297 83.2983 88.2286
HGPA 67.4533 77.8447 83.9824
MCLA 71.9764 83.1845 87.9411
doi:10.1371/journal.pone.0013803.t014
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as a marker gene selector. It is defined as
m1{m2 ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
s2
1zs2
2
q , where mi
and si are as defined in Eqn. 13. The %CA is also computed for
the clustering solutions for the dataset consisting of only the
marker genes selected using the t-statistic. The average %CA
scores over 50 runs of each of the clustering algorithms for the
SRBCT dataset consisting of the initially selected 200 genes,
marker genes selected using the t-statistic and marker genes
selected using the SNR statistic are reported in Table 14. It is
evident from the table that the performance of the algorithms gets
improved irrespective of the clustering algorithm used, when
applied to the dataset with the identified marker genes only.
Moreover, the performance of the SNR statistic is found to be
better compared to that of the t-statistic. This indicates the ability
of the gene markers to distinguish the different classes of samples in
the datasets.
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